Ferrocifen type anti cancer drugs G Jaouen, A Vessières, S Top Chemical Society Reviews 44 (24), 8802-8817, 2015 | 551 | 2015 |
Bioorganometallics: biomolecules, labeling, medicine G Jaouen John Wiley & Sons, 2006 | 523 | 2006 |
Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens … S Top, A Vessières, G Leclercq, J Quivy, J Tang, J Vaissermann, M Huché, ... Chemistry–A European Journal 9 (21), 5223-5236, 2003 | 498 | 2003 |
Ferrocene‐mediated proton‐coupled electron transfer in a series of ferrocifen‐type breast‐cancer drug candidates E Hillard, A Vessières, L Thouin, G Jaouen, C Amatore Angewandte Chemie 118 (2), 291-296, 2006 | 490 | 2006 |
Bioorganometallic chemistry: structural diversity of organometallic complexes with bioligands and molecular recognition studies of several supramolecular hosts with … RH Fish, G Jaouen Organometallics 22 (11), 2166-2177, 2003 | 399 | 2003 |
Bioorganometallic chemistry: a future direction for transition metal organometallic chemistry? G Jaouen, A Vessieres, IS Butler Accounts of chemical research 26 (7), 361-369, 1993 | 382 | 1993 |
The first organometallic selective estrogen receptor modulators (SERMs) and their relevance to breast cancer G Jaouen, S Top, A Vessieres, G Leclercq, MJ McGlinchey Current medicinal chemistry 11 (18), 2505-2517, 2004 | 305 | 2004 |
Studies on organometallic selective estrogen receptor modulators.(SERMs) Dual activity in the hydroxy-ferrocifen series S Top, A Vessieres, C Cabestaing, I Laios, G Leclercq, C Provot, ... Journal of Organometallic Chemistry 637, 500-506, 2001 | 303 | 2001 |
Modification of the estrogenic properties of diphenols by the incorporation of ferrocene. Generation of antiproliferative effects in vitro A Vessieres, S Top, P Pigeon, E Hillard, L Boubeker, D Spera, G Jaouen Journal of medicinal chemistry 48 (12), 3937-3940, 2005 | 244 | 2005 |
Ferrocenyl hydroxytamoxifen: a prototype for a new range of oestradiol receptor site-directed cytotoxics S Top, J Tang, A Vessières, D Carrez, C Provot, G Jaouen Chemical Communications, 955-956, 1996 | 224 | 1996 |
Rhenium Carbonyl Complexes of. beta.-Estradiol Derivatives with High Affinity for the Estradiol Receptor: An Approach to Selective Organometallic Radiopharmaceuticals S Top, H El Hafa, A Vessieres, J Quivy, J Vaissermann, DW Hughes, ... Journal of the American Chemical Society 117 (32), 8372-8380, 1995 | 223 | 1995 |
Electrochemical parameters and techniques in drug development, with an emphasis on quinones and related compounds EA Hillard, FC de Abreu, DCM Ferreira, G Jaouen, MOF Goulart, ... Chemical Communications, 2612-2628, 2008 | 204 | 2008 |
Facile route to ferrocifen, 1-[4-(2-dimethylaminoethoxy)]-1-(phenyl-2-ferrocenyl-but-1-ene), first organometallic analogue of tamoxifen, by the McMurry reaction S Top, B Dauer, J Vaissermann, G Jaouen Journal of organometallic chemistry 541 (1-2), 355-361, 1997 | 202 | 1997 |
Bioorganometallics: Future Trends in Drug Discovery, Analytical Chemistry, and Catalysis, EA Hillard, G Jaouen Organometallics 30 (1), 20-27, 2011 | 199 | 2011 |
Ferrocenyl quinone methides as strong antiproliferative agents: formation by metabolic and chemical oxidation of ferrocenyl phenols P Herson, GØ Jaouen, D Mansuy Angew. Chem 121, 9288-9290, 2009 | 199 | 2009 |
Ferrocifens and ferrocifenols as new potential weapons against breast cancer A Nguyen, A Vessières, EA Hillard, S Top, P Pigeon, G Jaouen Chimia 61 (11), 716-716, 2007 | 192 | 2007 |
Facile syntheses of optically active 2-substituted indanones, indanols, tetralones, and tetralols via their chromium tricarbonyl complexes G Jaouen, A Meyer Journal of the American Chemical Society 97 (16), 4667-4672, 1975 | 179 | 1975 |
Medicinal organometallic chemistry G Jaouen, N Metzler-Nolte Springer, 2010 | 177 | 2010 |
New paradigms for synthetic pathways inspired by bioorganometallic chemistry G Jaouen, S Top, A Vessières, R Alberto Journal of Organometallic Chemistry 600 (1-2), 23-36, 2000 | 161 | 2000 |
A [3] ferrocenophane polyphenol showing a remarkable antiproliferative activity on breast and prostate cancer cell lines D Plazuk, A Vessières, EA Hillard, O Buriez, E Labbé, P Pigeon, ... Journal of medicinal chemistry 52 (15), 4964-4967, 2009 | 153 | 2009 |